Searchable abstracts of presentations at key conferences in endocrinology
ISSN 1470-3947 (print)
| ISSN 1479-6848 (online)
Endocrine Abstracts
Menu
Search
Issues/Conferences
Cite
About
Our Services
Policies
Contact
Disclaimer
Search
Issues/Conferences
Cite
About
Our Services
Policies
Contact
Disclaimer
Previous issue
|
Volume 56
|
ECE2018
|
Next issue
20th European Congress of Endocrinology
Barcelona,
Spain
19 May 2018 - 22 May 2018
All volumes
0097 BES2023
0096 UKINETS2023
0095 BSPED2023
0094 SFEBES2023
0093 EYES2023
0092 ETA2023
0091 SFEEU2023
0090 ECE2023
0089 NANETS2022
0088 BES2022
0087 UKINETS2022
0086 SFEBES2022
0085 BSPED2022
0084 ETA2022
0083 EYES2022
0082 SFEEU2022
0081 ECE2022
0080 UKINETS2021
0079 BES2021
0078 BSPED2021
0077 SFEBES2021
0076 CHD2021
0075 EYES2021
0074 SFENCC2021
0073 ECE2021
0072 UKINETS2020
0071 BES2020
0070 ECE2020
0069 SFENCC2020
0068 UKINETS2019
0067 EYES2019
0066 BSPED2019
0065 SFEBES2019
0064 BES2019
0063 ECE2019
0062 EU2019
0061 OU2019
0060 UKINETS2018
0059 SFEBES2018
0058 BSPED2018
0057 BES2018
0056 ECE2018
0055 SFEEU2018
0054 NuclearReceptors2018
0053 OU2018
0052 UKINETS2017
0051 BSPED2017
0050 SFEBES2017
0049 ECE2017
0048 SFEEU2017
0047 Theranostics2016
0046 UKINETS2016
0045 BSPED2016
0044 SFEBES2016
0043 WCTD2016
0042 Androgens2016
0041 ECE2016
0040 ESEBEC2016
0039 BSPED2015
0038 SFEBES2015
0037 ECE2015
0036 BSPED2014
0035 ECE2014
0034 SFEBES2014
0033 BSPED2013
0032 ECE2013
0031 SFEBES2013
0030 BSPED2012
0029 ICEECE2012
0028 SFEBES2012
0027 BSPED2011
0026 ECE2011
0025 SFEBES2011
0024 BSPED2010
0023 BSPED2009
0022 ECE2010
0021 SFEBES2009
0020 ECE2009
0019 SFEBES2009
0018 MES2008
0017 BSPED2008
0016 ECE2008
0015 SFEBES2008
0014 ECE2007
0013 SFEBES2007
0012 SFE2006
0011 ECE2006
0010 SFE2005
0009 BES2005
0008 SFE2004
0007 BES2004
0006 SFE2003
0005 BES2003
0004 SFE2002
0003 BES2002
0002 SFE2001
ECE 2018, 19 - 22 May 2018; Barcelona, Spain
Summary
Abstract Book
Programme
Volume Editors
Abstracts
Contents
20th European Congress of Endocrinology 2018
Prize Lectures and Biographical Notes
The European Journal of Endocrinology Prize Lecture
A gut feeling about glucagon
ea0056eje1
The European Journal of Endocrinology Prize Lecture
ea0056eje1biog
The Geoffrey Harris Prize Lecture
Geoffrey Harris Award
ea0056gh1
The Geoffrey Harris Prize Lecture
ea0056gh1biog
European Hormone Medal Lecture
Unraveling Secrets of the Hypothalamic-Pituitary-Gonadal Axis
ea0056ehm1
European Hormone Medal Lecture
ea0056ehm1biog
Clinical Endocrinology Trust Lecture
Growth Hormone: not too much… not too less..!
ea0056cet1
Clinical Endocrinology Trust Lecture
ea0056cet1biog
Plenary Lectures
Contraception: Past and future
Contraception: past, present, and future
ea0056pl1
Bone regulates the Brain
Bone Regulates the Brain to Control Appetite
ea0056pl2
The wonder world of GnRH neurons
The wonder world of GnRH neurons - cracking the pulse generator
ea0056pl3
The Retina as a Window for Exploring the Brain in Diabetes
The Retina as a Window for Exploring the Brain in Diabetes
ea0056pl4
The link between insulin and fatty liver
The link between insulin and fatty liver
ea0056pl5
Does therapy for thyroid dysfunction decrease mortality?
Does therapy for thyroid dysfunction decrease mortality?
ea0056pl6
Metabolic control of longevity
Anti-obesity effect in mice and monkeys of partial inhibition of PI3K[alpha]
ea0056pl7
Symposia
Predicting events in autoimmune thyroid diseas
The THEA score in familial thyroid dysfunction. Predictive factors of autoimmune thyroid disease
ea0056s1.1
IgG4 related thyroid autoimmune disease
ea0056s1.2
New scores for the prediction of Graves' disease
ea0056s1.3
Salt & Sweet
Hyponatremia and mortality: moving beyond associations
ea0056s2.1
Hereditary diabetes insipidus
ea0056s2.2
Going hedonic - the role of FGF21 in the preference for sweet and alcohol
ea0056s2.3
Bile Acid & Microbiota (Endorsed by Endocrine Connections)
Crosstalk between bile acids and the gut microbiota - influence on host metabolism
ea0056s3.1
Subclinical hypothyroidism is 'not' a disease (Contra)
ea0056s3.2
Bile acids and metabolic effects of bariatric surgery
ea0056s3.3
Environmental effects on endocrine functions
Developmental exposures to endocrine disrupting chemicals (EDCs) reprogram the epigenome to increase risk for hormone-dependent cancers and other diseases of adilthood
ea0056s4.1
Iodine deficiency in pregnancy and development of offspring
ea0056s4.2
Environmental contaminants and endocrine disruption: the story of obesogens
ea0056s4.3
The role of sperm epigenome in fertility and inheritance
The quality control of the male germline transcriptome
ea0056s5.1
Abstract unavailable
ea0056s5.2
Mechanisms of epigenetic inheritance through sperm: lessons we have learnt from model organisms
ea0056s5.3
Precision Medicine for diabetes (Endorsed by the European Journal of Endocrinology)
Pharmacogenetics in type 2 diabetes: precision medicine or discovery tool?
ea0056s6.1
Genetics can help to improve precision medicine in diabetes
ea0056s6.2
Precision Nutrition in Obesity: gene-diet interactions
ea0056s6.3
Expanding the spectrum of thyroid hormone use (Endorsed by the European Journal of Endocrinology)
Triac: hormone, metabolite and drug.
ea0056s7.1
Tetrac as an antiangiogenic agent in cancer
ea0056s7.2
Thyroid hormones, metabolites, and analogs: Potential therapies for non-alcoholic fatty liver disease and other metabolic conditions
ea0056s7.3
Bone fragility - from bench to clinic
Clinical spectrum of new monogenic forms of osteoporosis
ea0056s8.1
Abstract unavailable
ea0056s8.2
Hypophosphatasia - diagnosis and treatment
ea0056s8.3
EAA /ESE Session: Male gonadal function versus general health and vice versa
Abstract unavailable
ea0056s9.1
Klinefelter syndrome - a challenge for endocrinologists
ea0056s9.2
Does 'healthy obesity' exist in andrology?
ea0056s9.3
Hot topics in NETs
Whole genome landscape in pancreatic neuroendocrine tumours
ea0056s10.1
Abstract unavailable
ea0056s10.2
Treatment update on carcinoid syndrome and carcinoid heart disease
ea0056s10.3
Novel aspects of Craniopharyngioma
Molecular pathogenensis of craniopharyngioma
ea0056s11.1
Bariatric surgery as treatment in craniopharyngioma
ea0056s11.2
The psychosocial, neuroendocrine and cognitive effects of childhood craniopharyngioma
ea0056s11.3
Why do fractures occur in endocrine disorders, and how should they be handled?
Abstract unavailable
ea0056s12.1
Bone quality evaluation in Pituitary diseases
ea0056s12.2
Parathyroid dysfunctions - bone mass and fractures in primary hyperparathyroidism
ea0056s12.3
The colours of fat
Brown adipose tissue as an endocrine organ
ea0056s13.1
Adipose tissue browning in mice and men
ea0056s13.2
Browning of adipose tissue in humans
ea0056s13.3
Neuroendocrine basis of reproductive disorders
Developmental wiring of GnRH neurons
ea0056s14.1
Neuroendocrinology right from the nose: Genetics and pathophysiology of the olfacto-genital syndrome (Kallmann syndrome)
ea0056s14.2
Abstract unavailable
ea0056s14.3
EYES: New aspects in the study of neuroendocrine diseases
Introduction to EYES
ea0056s15.1
Abstract unavailable
ea0056s15.2
Epigenetic and metabolic reprogramming of SDH deficient pheochromocytomas and paragangliomas
ea0056s15.3
Abstract unavailable
ea0056s15.4
Abstract unavailable
ea0056s15.5
Abstract unavailable
ea0056s15.6
Changing practice in the management of thyroid neoplasms
New steps in the genomic alterations of thyroid malignancies
ea0056s16.1
Composite approach in the evaluation and management of thyroid nodule
ea0056s16.2
Abstract unavailable
ea0056s16.3
Recent advances in Primary Adrenal Macronodular Hyperplasia
Adrenal development and benign tumor formation
ea0056s17.1
Genetics of Primary Bilateral Macronodular Adrenal Hyperplasia: when and what to test
ea0056s17.2
Diagnosis and Management of Primary Adrenal Macronodular Hyperplasia
ea0056s17.3
Borderline testosterone and metabolic outcomes among sexes: clinical relevance
Sex hormones, obesity and type 2 diabetes-is there a link?
ea0056s18.1
Relevant therapies in PCOS
ea0056s18.2
Testosterone, obesity and the metabolic syndrome in males-do we need to replace steroids?
ea0056s18.3
New Aspects of Pituitary Regulation
Cytoskeleton, pharmacologic resistance and clinical aggressiveness in pituitary tumours
ea0056s19.1
What fat does with your pituitary
ea0056s19.2
How cancer treatment effects your pituitary
ea0056s19.3
All you need to know about lipodystrophy (Endorsed by Endocrine Connections)
Lipodystrophy as a model for prevalent insulin resistance
ea0056s20.1
Acquired forms of lipodystrophy
ea0056s20.2
Lipodystrophies, diagnosis and treatment: a step-by-step approach
ea0056s20.3
The Dance of Adrenal and Gonads (Endorsed by Endocrine Connections)
Abstract unavailable
ea0056s21.1
Management of phaeochromocytoma during pregnancy
ea0056s21.2
Fertility in Congenital Adrenal Hyperplasia
ea0056s21.3
The fatty bone
Abstract unavailable
ea0056s22.1
Bone marrow adipose tissue: starving for attention
ea0056s22.2
Cross-talk between bone marrow and peripheral adipose tissue in man
ea0056s22.3
Pre-diabetes
Abstract unavailable
ea0056s23.1
Abstract unavailable
ea0056s23.2
Treatment of Pre-Type 2 Diabetes
ea0056s23.3
Ups and downs of hypothalamo-pituitary hormones
How Does Pituitary Release its Hormones?
ea0056s24.1
Peripheral activities of growth hormone-releasing hormone (GHRH)
ea0056s24.2
The role of pituitary hormones (among others) in the generation of metabolic stress responses
ea0056s24.3
Late Breaking
Extracellular Vesicles: from waste-containers to new opportunities
ea0056s25.1
Senescence-associated reprogramming promotes cancer stemness
ea0056s25.2
LEAP2 is an Endogenous Antagonist of the Ghrelin Receptor
ea0056s25.3
Cortisol: Too much of a Good Thing
Genetics of Cushing's disease
ea0056s26.1
Hypercortisolism and the brain
ea0056s26.2
Differentiating Cushing from Pseudo-Cushing
ea0056s26.3
Emerging treatments in osteoporosis
Abstract unavailable
ea0056s27.1
Novel therapies: PTH-related protein and sclerostin inhibition
ea0056s27.2
Sequential and combination therapy for osteoporosis.
ea0056s27.3
Endocrinology Meets Immunology
Abstract unavailable
ea0056s28.1
Abstract unavailable
ea0056s28.2
Immunotherapy Related Endocrinopathies
ea0056s28.3
Thyroid hormone action: regulation and clinical implications
Tissue-specific regulation of thyroid hormone action
ea0056s29.1
Thyroid hormone economy in human aging
ea0056s29.2
Abstract unavailable
ea0056s29.3
Disorders of Sexual Development (DSD)
Abstract unavailable
ea0056s30.1
Atypical Genital Development and Hypospadias: a Pediatric Urology perspective from Etiology to Surgery
ea0056s30.2
Brain structure and function in gender dysphoria
ea0056s30.3
Special Symposium: Bone & Vitamin D (Endorsed by Endocrine Connections)
Free and bound vitamin D and health outcomes.
ea0056ss1.1
Vitamin D in critical illness
ea0056ss1.2
The effects of Vitamin D deficiency on macrophages function, cholesterol metabolism and cardiometabolic disease
ea0056ss1.3
Guidelines: ESE - ENSAT guidelines on the management of adrenocortical carcinoma in adults
ESE - ENSAT guidelines on the management of adrenocortical carcinoma in adults
ea0056gl1.1
Abstract unavailable
ea0056gl1.2
Abstract unavailable
ea0056gl1.3
Abstract unavailable
ea0056gl1.4
Abstract unavailable
ea0056gl1.5
Abstract unavailable
ea0056gl1.6
Endo-ERN: concrete examples of added value for patient care
Introduction, structure, and virtual consultation using the EU-ERN CPMS
ea0056ern1.1
Caring for endocrinology across the life span: DSD and Hypogonadotropic hypogonadism
ea0056ern1.2
ESE Endo-ERN symposium: Patient and family perspectives, Manuela Brosamle, Endo-ERN ePAG
ea0056ern1.3
New Scientific Approaches
(1)
Abstract unavailable
ea0056nsa1
A comprehensive map of splicing alterations in small cell lung cancer
ea0056nsa2
Reprgrammin strategies to obtain functional endocrine units; focus on the adrenal cortex
ea0056nsa3
3D visualisation of the HPG axis in mice and humans
ea0056nsa4
Circulating miRNAs in endocrine tumours
ea0056nsa5
Abstract unavailable
ea0056nsa6
Debates
Adrenal venous sampling vs. imaging for primary aldosteronism: beware of the caveats! (Endorsed by the European Journal of Endocrinology)
Adrenal venous sampling vs imaging for primary aldosteronism
ea0056d1.1
Against - Adrenal venous sampling vs. imaging for primary aldosteronism: beware of the caveats!
ea0056d1.2
Receptor profiling is useful for predicting pituitary therapy (Endorsed by the European Journal of Endocrinology)
Abstract unavailable
ea0056d2.1
Abstract unavailable
ea0056d2.2
Subclinical hypothyroidism is a disease
FOR - subclinicl hypothyroidism is a disease
ea0056d3.1
Abstract unavailable
ea0056d3.2
AMH as the Primary Marker for Fertility
AMH is the primary marker for fertility (Pro)
ea0056d4.1
Debate: AMH as the primary marker for fertility
ea0056d4.2
Pregnant women should be screened for thyroid hormones and antibodies
Abstract unavailable
ea0056d5.1
AGAINST: 'Pregnant women should be screened for thyroid hormones and antibodies'
ea0056d5.2
Endocrine disruptors: Regulatory vs. Scientific Perspectives (Endorsed by Endocrine Connections)
Abstract unavailable
ea0056d6.1
Endocrine disruptors: Regulatory vs. Scientific Perspectives (regulatory view point)
ea0056d6.2
Meet the Expert Sessions
(1)
Using diabetes technologies to improve patient self care
ea0056mte1
Acromegaly: Optimal management after surgery
ea0056mte2
Managing delayed puberty
ea0056mte3
Osteoporosis in men: management of bone health in the endocrine outpatient clinic
ea0056mte4
Medullary thyroid cancer beyond surgery
ea0056mte5
Long-term implications of hypoglycaemia in diabetes Dr Ilhan Satman, Istanbul University, Turkey
ea0056mte6
Difficult cases of differentiated thyroid cancer
ea0056mte7
Hormone replacement for the travelling patient
ea0056mte8
Premature ovarian insufficiency: an endocrine perspective
ea0056mte9
The effect of gender-affirming therapy on bone in transgender persons
ea0056mte10
How to integrate PCSK9 inhibitors into hyperlipidemia management
ea0056mte11
Controversies in NETs: Is high dose SSA treatment relevant and who needs hemicolectomy?
ea0056mte12
Erectile dysfunction
ea0056mte13
Vitamin D for everybody?
ea0056mte14
Your emergency consult about hyponatraemia
ea0056mte15
Adrenal Incidentaloma
ea0056mte16
Abstract unavailable
ea0056mtbs1
Single-cell technologies in development and disease with a special emphasis on endocrine systems
ea0056mtbs2
Watch out for noncanonical mechanisms of thyroid hormone action!
ea0056mtbs3
Nurse Sessions
(1)
Abstract unavailable
ea0056n1.1
Abstract unavailable
ea0056n1.2
Abstract unavailable
ea0056n1.3
Abstract unavailable
ea0056n2.1
Abstract unavailable
ea0056n2.2
Abstract unavailable
ea0056n2.3
Abstract unavailable
ea0056n2.4
Nursing Management of Congenital Adrenal Hyperplasia (CAH): - Education, Managment and use of Multi-Media Technology
ea0056n3.1
Abstract unavailable
ea0056n4.1
Abstract unavailable
ea0056n4.2
Comparison of glucose, peak growth hormone & peak cortisol levels during insulin tolerance testing with two different doses (0.15 vs 0.10 U/kg)
ea0056n4.3
Cooperation between an endocrine nurse, psychologist and physician and their role in the care of depression in patients treated with multi kinase inhibitors due thyroid cancer
ea0056n4.4
Abstract unavailable
ea0056n4.5
Oral Communications
Benign thyroid diseases
Familial gestational hyperthyroidism caused by Val597ile mutant of TSH receptor gene with human chorionic gonadotropin hypersensitivity
ea0056oc1.1
Relationship between TSH values in the first trimester of pregnancy and obstetric and neonatal complications
ea0056oc1.2
Thyroid hormone replacement therapy for subclinical hypothyroidism in adults: systematic review and meta-analysis of randomized-controlled trials
ea0056oc1.3
The impact of obligatory iodine prophylaxis on thyroid volume in schoolchildren
ea0056oc1.4
Low free T3 levels within the reference range independently predict cardiovascular mortality in the general population
ea0056oc1.5
Look who is controlling your gonads!
The in vivo and in vitro effects of kisspeptin on human ovarian function
ea0056oc2.1
Overexpressed kisspeptin/Kiss1R system in human granulosa cells may be involved in the pathogenesis of polycystic ovary syndrome (PCOS) by inhibiting ovulation
ea0056oc2.2
Whole exome sequencing in non-obstructive azoospermia allows the identification of a high-risk subgroup of infertile men for undiagnosed Fanconi Anemia, a cancer-prone disease
ea0056oc2.3
Novel role of central ceramide signaling in mediating obesity-induced precocious puberty
ea0056oc2.4
Effect of thyroxine replacement on leydig cell and sertoli cell function in men with hypothyroidism
ea0056oc2.5
New insights in bone disorders
A Phase 3 randomized, double-blind, placebo-controlled study investigating the efficacy and safety of Burosumab, an anti-FGF23 antibody, in adult X-Linked Hypophosphatemia (XLH)
ea0056oc3.1
Can a bone protein protect against muscular dystrophy?
ea0056oc3.2
[18F]-FDG PET/CT imaging: A tool to reveal the metabolic functions of bone marrow adipose tissue
ea0056oc3.3
Renal function change in chronic hypoparathyroidism patients treated with recombinant human parathyroid hormone (1-84) (rhPTH[1-84]) and in a historical control cohort treated with standard therapy
ea0056oc3.4
Change in bone mineral density during the first 10 years of gender affirming hormonal treatment in transwomen and transmen
ea0056oc3.5
Novel insights into prediabetes and type 2 diabetes
Dietary intervention modulates the expression of the splicing machinery in patients at high-risk of type 2 diabetes development: clinical implications
ea0056oc4.1
Toe brachial index predicts major adverse cardiovascular events in patients with type 2 diabetes
ea0056oc4.2
Effects of TRAIL delivery on an experimental model of type 2 diabetes and diabetic nephropathy
ea0056oc4.3
Association between prediabetes and incidence of chronic kidney disease, incident albuminuria, or worsening of kidney function: a secondary analysis of the SPRINT trial
ea0056oc4.4
The impact of prediabetes in lung function: data from the ILERVAS project
ea0056oc4.5
Diving deep into adrenal cortex diseases
Is adrenal computed tomography accurate for the diagnosis of unilateral primary aldosteronism? A retrospective international cohort study
ea0056oc5.1
Steroid profiling by liquid chromatography tandem mass spectrometry in a large cohort of patients with adrenal incidentalomas
ea0056oc5.2
PRKACA L206R mutation in adrenal Cushing's syndrome makes PKA RII[beta] susceptible for caspase-mediated cleavage
ea0056oc5.3
Assessment of Tissue Sodium Content by 23Na-MRI in Patients with Adrenal Insufficiency - a Pilot Study
ea0056oc5.4
Cullin 3 is a partner of Armadillo Repeat Containing 5 (ARMC5), the product of the gene responsible for Primary Bilateral Macronodular Adrenal Hyperplasia
ea0056oc5.5
Genetic and environmental determinants of obesity and insulin resistance
5[beta]-reductase (AKR1D1) is a potent regulator of hepatic insulin sensitivity, carbohydrate and lipid metabolism
in vitro
and
in vivo
ea0056oc6.1
Deep transcranial magnetic stimulation acutely modulates neuro-endocrine pathways underlying obesity
ea0056oc6.2
Visceral fat assessment in lamin A/C mutation carriers: phenotype -genotype correlation
ea0056oc6.3
Anthropometric measurements and metabolic syndrome in relation to glucocorticoid receptor polymorphisms in (local) corticosteroid users
ea0056oc6.4
Associations of different body fat deposits with serum 25-hydroxyvitamin D concentrations
ea0056oc6.5
Genomic and clinical aspects of endocrine tumours
Molecular classification of benign adrenocortical tumors: an integrated genomic study
ea0056oc7.1
Urine steroid metabolomics as a diagnostic tool for detection of adrenocortical malignancy - a prospective test validation study
ea0056oc7.2
LncRNAs profiling reveals epigenetic heterogeneity among human parathyroid tumor
ea0056oc7.3
Germline mutations in the mitochondrial 2-oxoglutarate/malate carrier (SLC25A11) gene confer predisposition to metastatic paragangliomas
ea0056oc7.4
Randomized trial comparing phenoxybenzamine and doxazosine for preoperative treatment of patients with a pheochromocytoma (PRESCRIPT)
ea0056oc7.5
MicroRNAs as biomarkers in endocrine diseases
Plasma microRNA expression in patients with Cushing's disease differs from ACTH-ectopic Cushing's syndrome
ea0056oc8.1
MicroRNA expression profiling and functional annotation analysis of their targets in patients with diabetic kidney disease
ea0056oc8.2
Circulating levels of microRNAs associate with blood pressure and left ventricular mass in primary hypertensive patients
ea0056oc8.3
Detecting blood micro-RNAs and proteins associated with Graves' disease and orbitopathy
ea0056oc8.4
MicroRNA profiles in diabetic octogenarians with and without historical and prospective hip fractures
ea0056oc8.5
Thyroid from basics to clinics
Increased urinary iodide precedes hypothyroidism in Dehal1 knockout mice
ea0056oc9.1
Anti-tumoral effects of metformin on metastatic bone lesions of thyroid cancer
ea0056oc9.2
A mouse model of BRAF V600E mutated papillary thyroid cancer imitating sporadic conditions
ea0056oc9.3
Identification of an epigenetic biomarker panel for predicting the development of distant metastases in differentiated thyroid cancer
ea0056oc9.4
Sentinel lymph node biopsy using methylene blue dye in papillary and medullary thyroid carcinomas and microcarcinomas in decision for lateral neck dissection
ea0056oc9.5
Cardiovascular aspects of endocrine diseases
Glucocorticoid replacement-doses and cardiovascular events in autoimmune Addison's disease - a population based retrospective cohort study
ea0056oc10.1
Canagliflozin attenuates the progression of atherosclerosis via reducing hyperlipidaemia and inflammation process in ApoE KO Mice
ea0056oc10.2
ARMC5 variants and risk of hypertension in African Americans: Minority Health-GRID study
ea0056oc10.3
Improvement in the control of hypertension in diabetic patients screened for hyperaldosteronism
ea0056oc10.4
Increased risk of antithyroid drug-induced agranulocytosis with amiodarone
ea0056oc10.5
Clinical practice in endocrine tumours: combining conventional and molecular features
Targeted molecular analysis in adrenocortical carcinomas: a way towards improved personalized prognostication
ea0056oc11.1
Molecular classifiers refine the prognostic stratification of adrenocortical carcinoma
ea0056oc11.2
Clinical and histopathological differences between MEN1 carriers and MEN1 phenocopy patients
ea0056oc11.3
Update in the genetic landscape of Cushing's Disease: TP53 and a new deubiquitinase in spotlight
ea0056oc11.4
Natural history of Rathke's Cleft Cysts: a multicenter experience
ea0056oc11.5
Novel aspects of puberty development and Cushing's disease
Growth hormone signaling in leptin receptor expressing cells, but not in Kiss1 expressing neurons, regulates the timing of puberty
ea0056oc12.1
Oligogenicity in Kallmann syndrome - an underestimated phenomenon?
ea0056oc12.2
Evaluation of genetic predisposition in severe and mild phenotypes of isolated hypogonadotropic hypogonadism
ea0056oc12.3
Late-night salivary cortisol (LNSC) levels in a Phase III study of long-acting pasireotide in patients with Cushing's disease (CD)
ea0056oc12.4
Diabetes mellitus and muscle weakness are independently associated with mortality in patients with Cushing's syndrome. Data from ERCUSYN
ea0056oc12.5
The curious case of growth hormone
Postoperative use of somatostatin analogs and mortality in patients with acromegaly
ea0056oc13.1
Time trends of mortality in patients with GH secreting and non-functioning pituitary adenoma
ea0056oc13.2
Molecular profiling for assistance to pharmacological treatment of acromegaly
ea0056oc13.3
Effects of pegvisomant on glucose metabolism in acromegaly: A meta-analysis of prospective interventional studies
ea0056oc13.4
Growth hormone acts in AgRP neurons to control energy expenditure during food restriction and promotes counter-regulatory responses to hypoglycemia via the ventromedial hypothalamus
ea0056oc13.5
What is new in gestational and type 1 diabetes?
Does insulin treatment differ in their impact on placental vascular circulation in obese and non obese women with gestational diabetes mellitus?
ea0056oc14.1
Profiling of activation patterns of placental mTOR in pregnancies complicated by gestational diabetes mellitus
ea0056oc14.2
Patrolling monocytes are activated in diabetes and provide protection to retinal vessels in the context of leukostasis
ea0056oc14.3
The variability of glycemia and the metabolic composition of brain cells in patients with type 1 diabetes mellitus
ea0056oc14.4
Type 1 diabetes mellitus: defining the best cut-off points of arterial stiffness for predicting cardiovascular risk according to the Steno Type 1 Risk Engine
ea0056oc14.5
Guided Posters
Acromegaly
Retinal vessel abnormalities in acromegaly
ea0056gp2
An insight into the putative risk factors for IGF-1/GH dichotomy during follow-up for acromegaly
ea0056gp3
Efficacy and safety of switching to pasireotide LAR monotherapy or in combination with pegvisomant in acromegaly patients controlled with combination therapy of somatostatin analogues and pegvisomant (PAPE study): a prospective, open-label 48 week study
ea0056gp4
The importance of MEN1 gene variants in AIP mutation negative FIPA patients
ea0056gp5
IGF-I response to pasireotide LAR treatment in acromegaly is mainly driven by somatostatin receptor subtype 2 expression
ea0056gp6
Familial cancer clustering in patients with pituitary adenoma
ea0056gp7
ACRONIS, a European observational study in patients with uncontrolled acromegaly who are being treated with long acting pasireotide: first interim analysis
ea0056gp8
Pregnancy and acromegaly - clinical outcomes from the Irish Pituitary Network
ea0056gp9
Human growth hormone (GH) isoforms during oral glucose tolerance test in patients with acromegaly and in healthy subjects
ea0056gp10
Observational, multicentre study to evaluate the effectiveness in routine clinical practice of Lanreotide Autogel 120 mg at extended dosing intervals (>4 weeks) for the treatment of acromegaly: SOMACROL study
ea0056gp11
Cumulative effects of growth hormone and insulin-like growth factor-1 exposure on cardiovascular, cerebrovascular and metabolic co-morbidities in acromegaly patients
ea0056gp12
Adrenal Case reports
Adrenal schwannoma presenting as an adrenal incidentaloma in a pregnant woman
ea0056gp13
Sporadic paraganglioma and the importance of genetic screening
ea0056gp14
Etomidate for the management of severe hypercortisolaemia in different clinical scenarios - a case series
ea0056gp15
Pheochromocytoma associated with cutaneous and uterine leiomyomatosis and renal cancer in a patient with a germline mutation in the FH gene
ea0056gp16
A rare cause of endocrine hypertension
ea0056gp17
Bilateral testicular masses and adrenal insufficiency in a young adult: is congenital adrenal hyperplasia the only possible diagnosis?
ea0056gp18
Nonclassical congenital adrenal hyperplasia in a young patient with Type 1a Glycogen storage disease: is there a novel link between glucose metabolism and adrenal steroidogenesis?
ea0056gp19
Cushing's syndrome revealing carney complex due to novel PRKAR1A mutation
ea0056gp20
The importance of the follow-up after bilateral adrenal adenomectomy for Cushing's syndrome
ea0056gp21
Adrenal clinical
Hypoadrenalism in advanced HIV: a pilot study
ea0056gp22
Nicotinamide Nucleotide Transhydrogenase as a novel treatment target in adrenocortical carcinoma
ea0056gp23
Germline CYP2W1*6 polymorphism is a new predictive marker of sensitivity to mitotane treatment in advanced adrenocortical carcinoma: a multicenter European study
ea0056gp24
Metabolic fingerprints after Cushing syndrome cure
ea0056gp25
Segmental adrenal venous sampling may give a key to solution about the debate of cosyntropin stimulation or not
ea0056gp26
The short synacthen test can be used to predict recovery of hypothalamo-pituitary-adrenal axis function and guide clinical practice
ea0056gp27
Immunohistochemical staining for histopathological subclassification of primary aldosteronism: nationwide 10-year results from Iceland
ea0056gp28
Salivary cortisol and cortisone in Cushing diagnosis - reference ranges and clinical cut off limits
ea0056gp29
The urinary cortisol metabolome in patients with adrenal insufficiency: dual-release hydrocortisone is less deleterious than conventional hydrocortisone therapy
ea0056gp30
Circular RNA circ0066659 functions as a competitive endogenous RNA by sponging miR-506-3p in adrenocortical carcinoma
ea0056gp31
Adrenal cortex
PRKACA L206R mutation in adrenal Cushing induces histone H1.4 hyper-phosphorylation
ea0056gp32
Alterations in Clock genes expression in human benign adrenal tumors
ea0056gp33
Effects of replication of the physiological and non-physiological cortisol rhythm on insulin sensitivity in muscle: a molecular in vitro analysis on synchronized muscular cells
ea0056gp34
The circadian rhythm of glucocorticoid administration entrains clock-controlled genes in blood mononuclear cells: a DREAM trial ancillary study
ea0056gp35
Identification of new ARMC5 missense mutations in Primary Bilateral Macronodular Adrenal Hyperplasia (PBMAH) and their functional studies in vitro
ea0056gp36
MicroRNA expression profiling in adrenal myelolipoma, adrenocortical cancer and adrenocortical adenoma
ea0056gp37
Identification of a new target of PRKAR1A (Carney complex gene): KCTD20 (potassium channel tetramerization domain containing 20) and study of its role in adrenal Cushing
ea0056gp38
Gene mutation analysis and overal survival among the patints with neuroendocrine tumors of the lung and gastroenteropancreatic neuroendocrine tumors
ea0056gp39
Long term imaging follow-up of non-functioning adrenal adenomas at Vilnius University Hospital Santaros Klinikos (VUHSK): 2010-2017
ea0056gp40
The need for depression screening in patients with adrenal incidentalomas and (possible) autonomous cortisol secretion - the role of integrated care
ea0056gp41
Adrenal medulla and NETs
Pituitary adenoma and pheochromocytoma/paraganglioma: a multicausal association of tumors
ea0056gp42
Ex vivo metabolomic profiling in phaeochromocytoma, paraganglioma and GIST tumours: lessons learned
ea0056gp43
Mortality in patients with Pheochromocytoma: a population-based study 1977-2016
ea0056gp44
The 10 Hounsfield Units cut-off value on unenhanced CT imaging is highly sensitive to diagnose pheochromocytoma: a multicenter study
ea0056gp45
Comparative study between incidental and symptomatic pheochromocytoma
ea0056gp46
Identifying active steroids, steroid receptors and pathways in the normal breast and their potential relationship to obesity and cancer development
ea0056gp47
In vitro studies reveal a potential therapeutic role of the combination of biguanides and statins for the treatment of prostate cancer
ea0056gp48
Targeted destruction of FSHR-positive cancer cells by a lytic Phor21-FSHb conjugate
ea0056gp49
Abstract unavailable
ea0056gp50
Evolution of mesenteric metastasis in small intestinal neuroendocrine tumours (SI-NETs)
ea0056gp51
Epidemiology and clinical significance of clinical hormonal syndromes in patients with neuroendocrine tumors
ea0056gp52
Bone and Osteoporosis
Online bots could help in prevention and treatment of osteoporosis
ea0056gp53
Effect of inhaled corticosteroidson trabecular bone score in patients with asthma
ea0056gp54
Association between diabetes and the risk of falls: a nationwide population-based study
ea0056gp55
The influence of adipose tissue and bone marrow fat on bone mineral density in short bowel syndrome
ea0056gp56
Kinesiotherapy rehabilitation program to correct deep core stability muscle dysfunction in patients with osteoporotic vertebral fractures
ea0056gp57
Investigating glucocorticoids as mediators of increased bone marrow adiposity during caloric restriction
ea0056gp58
Thirty-one men and women with145 spontaneous vertebral fractures after denosumab discontinuation: a single center observational study
ea0056gp59
Effects of anti-osteoporotic medications on glucose metabolism and the incidence of type 2 diabetes mellitus: a systematic review
ea0056gp60
Bone structural components and lean mass assessed by 3D-DXA in hip fracture patients
ea0056gp61
Inflammatory profile in monocytes of patients with Addison's disease and Vitamin D effects
ea0056gp62
Cardiovascular
OCT1 gene variants are associated with cardiovascular characteristics in non-diabetic, prediabetic and diabetic patients
ea0056gp63
Habitual dietary intake of n-3 polyunsaturated fatty acids and leptin gene expression in visceral and subcutaneous adipose tissues of non-diabetic adults
ea0056gp64
Decreased heart rate variability can predict future development of metabolic syndrome in Asian adults
ea0056gp65
Evaluation of irisin levels in chronic heart failure with preserved or reduced ejection fraction
ea0056gp66
Liraglutide prevented the deposition of Collagen in the animal model of Bleomycin-induced lung fibrosis
ea0056gp67
Turner syndrome and cardiovascular risk
ea0056gp68
Can monogenic severe hypertriglyceridemia be differentiated from polygenic forms through clinical features: data from APPROACH and COMPASS studies in FCS and non-FCS hypertriglyceridemic patients?
ea0056gp69
Changes in lipid profile 5 years after bariatric surgery: laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy
ea0056gp70
Diabetes Complications
Prevalence and risk factors of periodontitis in diabetic patients with or without metabolic syndrome
ea0056gp71
Toe-brachial index is associated more strongly with progression of diabetic nephropathy than ankle-brachial index in type 2 diabetic patients
ea0056gp72
The BMI and skeletal muscle mass as a risk factor of carotid atherosclerosis in patients with type 2 diabetes
ea0056gp73
Is liver stiffness associated with diabetic complications in patients with type 2 diabetes and non-alcoholic fatty liver disease?
ea0056gp74
Effects of post-transplant and pre-existing diabetes mellitus on graft function after kidney transplantation
ea0056gp75
Glucose variability and pregnancy outcomes in gestational diabetes mellitus: a prospective study
ea0056gp76
Patients with community acquired pneumonia are three times more likely to die if they have concomitant diabetes mellitus
ea0056gp77
Diabetic patients are old as theirs feet are old:the strongest association of foot pathology with mortality in diabetes
ea0056gp78
Outcomes of hyperglycemia in patients with and without diabetes mellitus hospitalized for infectious diseases
ea0056gp79
Self-reported low-energy fractures and associated risk factors in diabetic portuguese patients: a cross-sectional population-based study
ea0056gp80
Impaired cortisol and growth hormone counterregulatory responses during severe hypoglycemia in type 2 diabetes mellitus
ea0056gp81
Diabetes Epidemiology
Maternal exposure to air pollutants and risk of gestational diabetes mellitus in Taiwan
ea0056gp82
Prevalence and predictors of gestational diabetes mellitus: a nationwide multicenter prospective study
ea0056gp83
Incretin hormones in pathogenesis of secondary hyperglycaemia in patients with Cushing's disease and acromegaly
ea0056gp84
Association of glucagon-to-insulin ratio and nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus
ea0056gp85
Heart rate variability is related to concomitant glucose fluctuation in longstanding type 1 diabetes
ea0056gp86
Differential expression of apoptotic and low grade inflammatory markers in Alzheimer's disease compared to diabetes mellitus type 1 and 2
ea0056gp87
Gestational diabetes mellitus and continuous glucose monitoring system. A prospective study.
ea0056gp88
Depression screening in adults with diabetes
ea0056gp89
Nutritional composition of carbohydrate-rich gluten free products and glycemic index calculation of commercially available gluten free pasta
ea0056gp90
Analysis of health-related quality of life in patients with type 2 diabetes mellitus: results of an epidemiological study FORSIGHT-T2DM
ea0056gp91
Gestational Diabetes Mellitus is associated with increased risk of Non-Alcoholic Fatty Liver Disease: A population-based cohort study
ea0056gp92
Diabetes Therapy
Proinflammatory cytokines and endotoxemia level change in patients with type 2 diabetes and nonalcoholic fatty liver disease after hepatoprotective and probiotic therapy usage
ea0056gp93
Telemonitoring and Telemedicine for Type 2 Diabetes Care: Multi-center Randomized Controlled Trial
ea0056gp94
Randomized control study to compare security and efficacy of the new long acting analogues degludec and glargina U300 in people with type 1 Diabetes. Preliminary results of the Ineox study
ea0056gp95
Long term results and determinants of outcomes in primary health care diabetes prevention. The DE-PLAN project
ea0056gp96
Comparison of insulin degludec with Insulin glargin 300 units/ml in insulin-naive patients with type 2 diabetes mellitus
ea0056gp97
Adult-onset autoimmune diabetes: comparative analysis of classical and latent presentation
ea0056gp98
Optimal time for measuringglucose level to detect steroid induced hyperglycaemia
ea0056gp99
Effect of aerobic exercise training on serum malondialdehyde level and quality of life in type 2 diabetes
ea0056gp100
A healthier fat intake is associated with absence of diabetic retinopathy in patients with type 1 diabetes
ea0056gp101
Type 2 diabetes remission one year after bariatric surgery - a comparison between vertical sleeve gastrectomy and gastric bypass
ea0056gp102
Glycemic control and outcomes of patients admitted in the acute stroke unit
ea0056gp103
Validation of Friedewald formula for estimatinglow-density lipoprotein cholesterol in Korea: the Korea National Health and Nutrition Examination Survey, 2009-2011
ea0056gp104
Diabetes Translational
Acute insulin-induced hypoglycemia decreases systemic fibrinolytic balance in patients with type 1 diabetes
ea0056gp105
Transcranial duplexsonography in patients with type 1 diabetes and diabetic nephropathy
ea0056gp106
Cumulative effect of glucose regulation in Calbindin-D9k knockout mice
ea0056gp107
The effect of GLP-1 agonist treatment on serum betatrophin levels and comparison with insulin treatment in type 2 diabetes mellitus patients
ea0056gp108
High glucose stimulates mineralocorticoid receptor activity of retinal Muller glia cell
ea0056gp109
Knock-down of class 2a histone deacetylases (HDACs) in hepatocytes of healthy mice does not affect gluconeogenesis but is associated with increased hematopoiesis
ea0056gp110
Olfactory receptor OR51E1 mediates GLP-1 secretion in enteroendocrine L cells
ea0056gp111
Study on antioxidant and hypoglycemic effects of natural polyphenols in the experimental diabetes model
ea0056gp112
Diazoxide pretreatment improves pancreatic islet survival in vitro and functionality in vivo
ea0056gp113
Benefits of the association of triiodothyronine (T3) to insulin treatment for the glycemic control of alloxan-induced diabetic rats
ea0056gp114
Male AKR1D1 (5[beta]-reductase) knockout mice have altered pancreatic islet morphology and hormone secretion
ea0056gp115
The role of oncostatin m in the development of type 2 diabetes associated with obesity
ea0056gp116
Endocrine Case Reports
A rare case report of Graves disease with coexisting TSH producing pituitary adenoma
ea0056gp117
Abstract unavailable
ea0056gp118
Non-syndromic multiple insulinomas with atypical clinico-biological presentation in two adult patients: a specific entity?
ea0056gp119
Langerhans cell histiocytosis: diagnosis on thyroid aspirate
ea0056gp120
Coexistence of papillary thyroid cancer and malignancies of other organs in patients carrying CHEK2 gene mutations - case series.
ea0056gp121
A case of nivolumab induced fulminant type 1 diabetes
ea0056gp122
A rare case of type-2 familial partial lipodystrophy (FLD type 2) non-Dunnigan type with laminin A/C gene (LMNA) mutation causing multi-organ failure and diabetes mellitus
ea0056gp123
MODY - a diagnosis to be considered in diabetes
ea0056gp124
Hyperinsulinaemic hypoglycaemia in the three generations of a family with GCK, c.295T>C (p.Trp99Arg) mutation
ea0056gp125
Acromegaly and acromegaloidism, two rare insulin-resistance conditions in one patient: reason for GH-IGF-1 discrepancy?
ea0056gp126
Female Reproduction
Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome
ea0056gp127
Low-dose SKA Progesterone and Interleukin-10 modulate the inflammatory pathway in endometriotic cell lines
ea0056gp128
Impaired GLP-1 response predicts prediabetes in obese PCOS with adverse metabolic phenotype independent of BMI
ea0056gp129
Alterations in gonadotropin receptors and signal activation in granulosa lutein cells from women with polycystic ovary syndrome
ea0056gp130
Prevalence of mutations in the insulin receptor gene and lamin A/C gene in functional ovarian hyperandrogenism with insulin resistance
ea0056gp131
Women with PCOS display reduced cardiac vagal activity which is dependent on metabolic abnormalities
ea0056gp132
Favorable prognosis of pregnancies in 28 hypopituitary women: Retrospective multicentric study on 39 pregnancies
ea0056gp133
Abstract unavailable
ea0056gp134
Liquid chromatography-tandem mass spectrometry characterization of a broad serum and salivary steroid profile in classical form of polycystic ovary syndrome
ea0056gp135
Novel mechanisms and genes involved in the pathogenesis of primary ovarian insufficiency (POI) by whole-exome sequencing approach
ea0056gp136
Hypothalamo-pituitary-adrenal axis sensitivity in women with polycystic ovary syndrome
ea0056gp137
Neuroendocrinology
Hypermethylation of tumour suppressor genes in pituitary adenomas: contribution to oncogenesis and tumour behaviour
ea0056gp138
Why don't corticotroph tumours always produce Cushing disease?
ea0056gp139
New horizons in medical treatment of Bronchial Carcinoids: evidence from in vitro models
ea0056gp140
Reproductive and metabolic consequences of AMP-Activated Protein Kinase (AMPK) ablation in GnRH neurons
ea0056gp141
Preoperative SSA treatment positively affects the outcome of pituitary neurosurgery in acromegaly patients
ea0056gp142
Characterization and functional rescue of a nephrogenic diabetes insipidus causing S127F substitution in V2 vasopressin receptor
ea0056gp143
Genetics of binge-eating disorder (BED): a pilot study
ea0056gp144
Hyponatremia-associated mortality and volemia in patients on parenteral nutrition: a prospective multicenter study
ea0056gp145
Hyperglycemia causes a reduction in FSH levels following aberrant epigenetic regulation in the gonadotropes due to the increased glucose metabolism
ea0056gp146
Macrophages involvement in neuroendocrine tumor behaviour and progression
ea0056gp147
Mountain cycling ultramarathon effects on neuromuscular, immune and stress biomarkers
ea0056gp148
Obesity
Sex hormone-binding globulin is more than a sex steroid carrier: a New therapeutic target against obesity and non-alcoholic fatty liver disease
ea0056gp149
Use of ultrasonography as a simple diagnostic method to measure different abdominal fat layers and metabolic syndromeprediction
ea0056gp150
Improvement in insulin-mediated suppression of branched-chain amino acid flux is responsible for the post-bariatric surgery decrease in plasma branched-chain amino acid levels
ea0056gp151
Cell-derived extracellular vesicles as important intercellular messengers in obesity
ea0056gp152
How to better predict weight loss and type 2 diabetes remission after bariatric surgery? the potential role of genetic scoring systems in clinical practice
ea0056gp153
Eating and substance-related disorders after bariatric surgery
ea0056gp154
Changes in gut microbiota and metabolic profiles after sleeve gastrectomy
ea0056gp155
Pharmacological stimulation of p53 with low-dose doxorubicin ameliorates diet-induced nonalcoholic steatosis and steatohepatitis
ea0056gp156
Obesity is associated with a dysregulation in the splicing machinery components at the hepatic level: influence of metformin
ea0056gp157
Dietary intake of fat and oil are associated with expression of miR-143 and miR-34a in visceral and subcutaneous adipose tissues of adults: a nutriepigenetic study
ea0056gp158
Role of Elovl6 in the thermogenic action of brown and beige adipocyte during [beta]3-adrenergic receptor activation
ea0056gp159
Physiological regulation of brown adipose tissue in obesity by mild-cold exposure, a B3-agonist and exercise training at thermoneutrality
ea0056gp160
Cold induced thermogenesis is influenced by seasonal changes in outdoor temperature
ea0056gp161
Paediatrics, Developmental ' Female Reproduction
Biomonitoring infantile urinary sexual hormone profiles for investigation of the endocrine disruptors associated mini-puberty effects
ea0056gp162
Global DNA methylation since early infancy to adulthood in the offspring of women with polycystic ovary syndrome (PCOS)
ea0056gp163
Utilisation of dental services and dental pathologies identified in children and adolescents with osteogenesis imperfecta in the south west of England
ea0056gp164
Early childhood BMI rise, the adiposity rebound, associates with PCOS diagnosis and obesity at ages 31 and 46 years - analysis of 46-year growth data from birth to adulthood in PCOS
ea0056gp165
Endemic goiter and breasts diseases in adolescent girls
ea0056gp166
Impact of fetal exposure to testosterone on fetal insulin sensitivity tissues in female sheep: a morphological and molecular approach
ea0056gp167
Self-esteem, emotional stability, social anxiety disorder and suicidal behaviours among transgender youth before gender-affirmative treatment in spain
ea0056gp168
Glucose transporters in human placenta and its relation to birth weight
ea0056gp169
Association of glucocorticoid receptor gene (NR3C1) expression in HUVECs with glycemic targets during gestational diabetes treatment: a pilot randomized controlled study
ea0056gp170
Autoimmunity markers in turner syndrome patients
ea0056gp171
Parathyroid
A pilot study of the differences in miRNA expression profile in the blood serum between patients with malignant and benign parathyroid tumors
ea0056gp172
Excess of parathyroid hyperplasia incidence in subjects exposed to ionizing radiation after the CHNPP accident
ea0056gp173
The design and preliminary results of a phase 1 TransCon PTH trial in healthy volunteers
ea0056gp174
Diagnosis and management of pseudohypoparathyroidism and related disorders: first international consensus statement
ea0056gp175
Symptom burden and HRQoL reported among patients with chronic hypoparathyroidism: impact of treatment with rhPTH (1-84) and with standard therapy
ea0056gp176
Maintenance of key biochemical parameters with recombinant human parathyroid hormone (1-84) in patients with hypoparathyroidism: an analysis of a long-term, open-label, single-centre study
ea0056gp177
The global, prospective, observational PARADIGHM registry for patients with chronic hypoparathyroidism was expanded to capture recombinant human parathyroid hormone, rhPTH(1-84), use under routine clinical care
ea0056gp178
Stone risk profile analysis in patients with asymptomatic primary hyperparathyroidism
ea0056gp179
Five-year efficacy and safety of recombinant human parathyroid hormone 1-84 (rhPTH[1-84]) for the treatment of adults with chronic hypoparathyroidism: analysis from the open-label race study
ea0056gp180
Is there HIV-associated hypoparathyroidism?
ea0056gp181
Use of a Disease-Characteristic Questionnaire identified pain and cramps and neuro-vegetative symptoms as significantly elevated and affected by Medication in mainly well-controlled hypoparathyroid patients
ea0056gp182
A novel mutation in the calcium sensing receptor GENE IN AN Italian family affected by autosomal dominant hypocalcemia
ea0056gp183
Pituitary / Growth Hormone ' IGF Axis
Adrenal insufficiency induced by anti-PD-1/anti-PD-L1 therapy in patients with cancer: a series of cases
ea0056gp184
Long-term treatment with metyrapone in four patients with Cushing's disease
ea0056gp185
Primary posterior pituitary tumors: a unique neoplasm with hight morbidity
ea0056gp186
Erdheim-chester disease presenting with hypopituitarism and diabetes insipidus
ea0056gp187
Growth disorders in paediatric survivors of hematopoietic stem cell transplantation after chemotherapy-only conditioning- the experience of a single center
ea0056gp188
Association of IGF1 receptor autoantibodies with height and body size
ea0056gp189
Insulin sensitivity improves after disease control in acromegaly irrespective of treatment modality and despite an increase in intrahepatic lipid content: data from an investigator-initiated prospective trial
ea0056gp190
Ectopic Cushing's syndrome secondary to medullary thyroid carcinoma with apparent signs of hypercortisolism: a case report
ea0056gp191
A case series of endocrine immune-related adverse effects of checkpoint inhibitors
ea0056gp192
Hypophysitis due to immune checkpoint blockade: rising numbers.
ea0056gp193
Pituitary Basic
Olfactory marker protein regulates prolactin secretion and production by modulating Ca2+ and TRH signaling in lactotrophs
ea0056gp194
Filamin A (FLNA) phosphorylation inhibits SSTR2 signal transduction in GH-secreting pituitary tumor cells
ea0056gp195
E-cadherin expression is associated with the response to somatostatin analogues in patients with acromegaly
ea0056gp196
Efficacy of pharmacological USP8 inhibition in human Cushing's disease tumours in vitro
ea0056gp197
Ubiquitin specific peptidase 8 (USP8) in human corticotroph pituitary tumors- possible targets and mode of action
ea0056gp198
Prominent expression of MAX and MEG3, despite lack of mutations in MAX, suggest a potential role for 14q genes in pituitary adenomas
ea0056gp199
Pharmacological characterization of somatostatin receptor subtype 3 as a potential strategy to treat non-functioning pituitary adenomas
ea0056gp200
Epigenetic and post-transcriptional regulation of the SSTR5 gene in somatotropinomas
ea0056gp201
Pituitary Clinical
Endoscopic vs microscopic transsphenoidal surgery for Cushing's disease: a systematic review and meta-analysis
ea0056gp202
Factors predicting comorbidities in cured patients with Cushing's syndrome
ea0056gp203
Long-term efficacy and safety of once-monthly pasireotide in patients with Cushing's disease: A Phase III extension study
ea0056gp204
Predictors of response to long-acting pasireotide in patients with Cushing's disease during a Phase III study
ea0056gp205
Clinicopathological correlations in pituitary thyrotroph tumors from a cohort of 23 patients
ea0056gp206
Molecular profiling of non-functioning pituitary adenomas does not support pharmacological therapeutic options
ea0056gp207
The role of clomiphene citrate in the resolution of hypogonadism in male patients with prolactinomas under cabergoline therapy
ea0056gp208
Cabergoline - therapy for 121 giant invasive prolactinomas
ea0056gp209
Endocrine disorders in adults after allogenic hematopoietic stem cell transplant
ea0056gp210
A systematic review and meta-analysis of endocrine-related adverse events associated with immune checkpoint inhibitors
ea0056gp211
Predictors of failure to respond to fluid restriction and furosemide efficacy prediction in patients presenting Syndrome of Inappropriate Antidiuretic while receiving parenteral nutrition. Prospective Multicenter Study
ea0056gp212
Abstract unavailable
ea0056gp213
Reproduction
Sperm DNA fragmentation index as a promising predictive tool for male infertility diagnosis and treatment management
ea0056gp214
Alleviation of perfluorooctanesulfonate (PFOS)-induced disruption of blood-testis barrier by altering cell signaling molecule expression in human sertoli cells.
ea0056gp215
Sertoli cell-specific knockout of coxsackie and adenovirus receptor (Cxadr) disrupts the blood-testis barrier and causes impaired fertility
ea0056gp216
The first Belgian series of 56 patients with congenital hypogonadotropic hypogonadism (CHH): genetic and brain abnormalities
ea0056gp217
Bioassay-based characterization of novel androgens
ea0056gp218
Mitochondrial phenotype of FOXL2 variants associated with Blepharophimosis, Ptosis and Epicantus Inversus Syndrome (BPES)
ea0056gp219
Depletion of the primate-specific luteinizing-hormone receptor splice variant 'exon-6A' impairs LH-, but not hCG-mediated signaling in human primary granulosa cells
ea0056gp220
The value of androstenedione and DHEA-S levels in diagnosis of polycystic ovary syndrome in young women
ea0056gp221
Change in visceral fat and its relation with change in lipids in trans persons during hormonal therapy: results from a multicenter prospective study
ea0056gp222
GHR ablation in the brain or in leptin receptor expressing cells causes metabolic effects during pregnancy
ea0056gp223
Thyroid Cancer - Diagnostics & Treatments
Association between preoperative thyrotrophin and clinicopathological and aggressive features of papillary thyroid cancer
ea0056gp224
Germline mutations in KIF1B gene in two families with familial non-medullary thyroid cancer (FNMTC)
ea0056gp225
Significant acceleration in dynamics of medullary thyroid cancer markers concentration - report of 26 cases
ea0056gp226
The adverse effect of radioactive iodine therapy on bone marrow for differentiated thyroid cancer patients
ea0056gp227
Familial non-medullary thyroid carcinoma. Are we facing a different entity?
ea0056gp228
Is thyroid nodule size a factor to consider when deciding for fine-needle aspiration procedure?
ea0056gp229
Peptide receptor radionuclide therapy in patients with medullary thyroid carcinoma: predictors and pitfalls
ea0056gp230
Related recurrence factors in a Spanish cohort of differentiated thyroid carcinoma. Cadit-CAM Study
ea0056gp231
Imaging in clinical research devoted to medullary thyroid carcinoma: a systematic meta-analysis
ea0056gp232
Molecular profiling of a large papillary thyroid cancer series followed at a single center: data on mutation density, heterogeneity and phenotype-genotype correlations
ea0056gp233
Title Evaluation of the CCK-2-receptor agonist 177Lu-PP-F11N for peptide receptor radionuclide therapy (PRRT) of medullary thyroid carcinoma - First results of a phase 0 'Lumed' Study
ea0056gp234
Does body mass index influence the clinical stage, treatment response and course of the disease in patients with differentiated thyroid cancer?
ea0056gp235
Thyroid Cancer - Translational
Neural stem cells expressing cytosine deaminase and interferon-[beta] suppressed the growth and metastasis of anaplastic thyroid cancer cells
ea0056gp236
Comparison in survival of the seventh and eighth editions of the American Joint Commision on Cancer in a Spanish cohort of differentiated thyroid carcinoma: Cadit-CAM Study
ea0056gp237
Carrying mutations truncating CHEK2 protein predisposes to thyroid neoplasms - preliminary report
ea0056gp238
The capability of the Bethesda System Reporting for Thyroid Cytopathology (TBSRTC) in identifying of thyroid carcinoma
ea0056gp239
Orthotopic PDX Mouse Model of humanprimary Undifferentiated/Anaplastic thyroid carcinoma
ea0056gp240
Detection of lncRNAs in thyroid nodule as new tool for tumor diagnosis: analysis by Droplet Digital PCR in Fine Needle Aspiration biopsy
ea0056gp241
New markers of follicular thyroid cancer found with wide-panel next-generation sequencing
ea0056gp242
Prognostic value of N0 classification in differentiated thyroid cancer
ea0056gp243
Implementation of the British Thyroid Association thyroid nodule classification: a general UK hospital perspective
ea0056gp244
Dynamic risk stratification in the follow-up of children and adolescents with differentiated thyroid cancer
ea0056gp245
Thyroid non cancer
Genistein Increase Thyroid Hormone and 7 alpha-hydroxycholesterol concentrations in the liver of middle-aged male rats
ea0056gp246
Serum FT4 levels predict incidence of type 2 diabetes and cardiovascular disease in the general population
ea0056gp247
Thyroid function in early-treated adult PKU patients
ea0056gp248
Abnormal thyroid enzymes in critically ill patients with no known prior thyroid disorder are an independent predictor of mortality
ea0056gp249
Assessment of carotid intima-media thickness and endothelial dysfunction in patients with hypothyroidism
ea0056gp250
Thyroid-specific mitochondrial dysfunction results in abnormal thyrotropin responses
ea0056gp251
T3 enhances GLUT2, PEPT1 and CD36/SR-B2 content in the intestinal epithelium of mice
ea0056gp252
Identification of new thyroid hormone dependent biomarkers for a successful replacement therapy
ea0056gp253
Proteome analysis of 3,5-T2-treated primary mouse hepatocytes
ea0056gp254
Thyroid non cancer - Autoimmune Thyroid disease/pregnancy
MicroRNA-4443 causes CD4+T cells dysfunction by targeting TRAF4 in Graves' disease
ea0056gp255
Are Thyrotropin Receptor Antibodies (TRAb) being used to diagnose the aetiology of hyperthyroidism?
ea0056gp256
Impact of TSH during the first trimester of pregnancy in obstetric and fetal complications: Usefulness of 2.5 mIU/l cut-off value
ea0056gp257
Influence of levothyroxine treatment in pregnant women with thyroid antiperoxidase antibodies
ea0056gp258
Thyroid disorders in patients with advanced neoplastic disease treated with immune checkpoints inhibitors
ea0056gp259
Early low dose rituximab for active thyroid eye disease: an effective and well tolerated treatment
ea0056gp260
Analysis of serum immunoglobulin G4 (IgG4) levels in euthyroid subjects with autoimmune thyroid disease and goiter in a Single Medical Center in Taiwan
ea0056gp261
Thyroid disorders in patients treated with inmune checkpoint inhibition therapy
ea0056gp262
Thyroid peroxidase antibody-positivity, but not isolated thyroglobulin antibody-positivity, is associated with non-thyroidal autoimmune diseases - a population study of more than 8000 Danes
ea0056gp263
Thyroid function in pregnant women; relation to Gestational Diabetes Mellitus (GDM) and Body Mass Index (BMI)
ea0056gp264
Thyroid non cancer - Benign Thyroid disease/ treatment
Nodule size as predictive factor of efficacy of radiofrequency ablation in treating autonomously functioning thyroid nodules
ea0056gp265
Radiofrequency ablation for benign symptomatic thyroid nodules: evaluation of clinical efficacy
ea0056gp266
Abstract unavailable
ea0056gp267
Response to Liothyronine therapy: Efficiacy of therapy and assessment of biochemical and physiological predictors
ea0056gp268
Tailored thyroxine treatment and gastric acid output in humans
ea0056gp269
Body composition changes during treatment of severe thyroid disorders. Is it always fat?
ea0056gp270
Personalised euthyroid targets based on a deterministic mathematical model
ea0056gp271
US-guided percutaneous microwave ablation for benign thyroid nodules: a prospective multicenter study
ea0056gp272
Abstract unavailable
ea0056gp273
Reduced quality of life and persistent complaints in treated hypothyroid patients
ea0056gp274
Poster Presentations: Adrenal and Neuroendocrine Tumours
Adrenal cortex (to include Cushing's)
Congenital adrenal hyperplasia in lady with severhirsutism and virilization due to 3B-hydroxysteroid dehydrogenase deficiency
ea0056p1
Endogenous stimulation in adrenal venous sampling (AVS) in differential diagnosis of primary hyperaldosteronism (PA)
ea0056p2
Congenital adrenal hyperplasia in 46xx male
ea0056p3
Diagnostic difficulties of Pseudo-Cushing states in women: about 24 cases
ea0056p4
Abstract unavailable
ea0056p5
Is adrenocortical carcinoma in children a different spectrum?
ea0056p6
Travelling distance and support group participation in patients with chronic adrenal insufficiency
ea0056p7
Abstract unavailable
ea0056p8
Evaluation of tumor size and hormonal status of elderly with adrenal incidentaloma
ea0056p9
Evaluation of adrenal function in Cushing's syndrome model rats
ea0056p10
Does Hemodialysis (HD) affect the overall testosterone (T) and luteinizing hormone (LH) levels in T-treated hypogonadal Congenital Adrenal Hyperplasia (CAH) male with associated chronic kidney disease (CKD)? A pilot single center matched case report
ea0056p11
A rare case of Cushing's syndrome due to adrenal adenoma complicated by familial adenomatous polyposis
ea0056p12
Hypoglycemic coma as first manifestation of primary adrenal insufficiency in a septic patient with severe hypokalemia and hypomagnesemia
ea0056p13
Preoperative treatment with metyrapone in patient with Cushing's syndrome due to adrenal adenoma: a pilot prospective study
ea0056p14
Clinical features of adrenal incidentalomas
ea0056p15
Rare incidence of primary adrenocortical carcinosarcoma: a case report
ea0056p16
Clinical and biochemical outcomes in surgically treated patients with primary aldosteronism. A multicentric retrospective study
ea0056p17
Intraoperative hypertensive crisis as a key symptom in a normotensive patient with primary aldosteronism - clinical case
ea0056p18
Adrenal insufficiency during prednisolone treatment in patients with polymyalgia rheumatica or giant cell arteritis - prevalence and clinical approach
ea0056p19
Prevalance of primary aldosteronism in hypertensive patients: epidemiological data from a tertiary centre
ea0056p20
Renin: a possible novel marker for the efficacy of pharmacological treatment of primary aldosteronism
ea0056p21
Conn Syndrome Presented with Muscle Weakness
ea0056p22
Large Oncocytic Adrenocortical Tumor with Uncertain Malignant Potential
ea0056p23
Conjugated steroids could be a reserve stock for rapid conversion into free ones during stress
ea0056p24
Presence of comorbidities related to hypercortisolism in a case series on adrenal incidentaloma (AI)
ea0056p25
Increased levels of Interleukin-6 in patients with primary and secondary hypocortisolism: A case-control study
ea0056p26
A new ARMC5 mutation responsible for primary bilateral macronodular adrenal hyperplasia
ea0056p27
Abstract unavailable
ea0056p28
Secondary adrenal insufficiency - is not this diagnosis often made too hasty?
ea0056p29
Assessing the new Primary Aldosteronism guidelines recommendation to omit confirmatory testing in selected patients - severity of hypokalaemia may be included
ea0056p30
Addison's disease due to adrenal tuberculosis: A case report
ea0056p31
How can cortisol-normalized adrenal venous sampling miss some Conn's adenoma
ea0056p32
ACTH stimulation test for study of primary aldosteronism
ea0056p33
Value of 131I-Norcholesterol scintigraphy in the evaluation of primary hyperaldosteronism
ea0056p34
A four months infant survival case of waterhouse-friderichsen syndrome
ea0056p35
Hypoaldosteronism induced by trimethroprim: hyponatremia is frequent
ea0056p36
Utility of adrenal venous sampling for the differential diagnosis of primary hyperaldosternoism subtypes
ea0056p37
Non-classic congenital adrenal hyperplasia clinics characteristics and treatment response cohort study
ea0056p38
A rare incidentaloma: adrenal schwannoma
ea0056p39
Cardiovascular risk in patient with incidentally detected adrenal masses - associated with metabolic syndrome and hypercortcism
ea0056p40
Outcomes of patients undergoing surgery for primary aldosteronism based on adrenal venous sampling and/or radiological lateralisation indicate a role for both modalities in case selection
ea0056p41
The response of C19- Δ5-steroids to ACTH stimulation
ea0056p42
Non-classical form of congenital adrenal hyperplasia in patients with bilateral incidentalomas - hormonal and genetic analysis
ea0056p43
Adrenal insufficiency in treated PMR: The tip of the iceberg
ea0056p44
Decreased quality of life in male patients with primary adrenal insufficiency of Indian origin
ea0056p45
The measurement of the renin-angiotensin-aldosterone system in patients with adrenal tumors with arterial hypertension
ea0056p46
The renin-angiotensin-aldosteron system in primary adrenal insufficiency
ea0056p47
Percutaneous microwave ablation of adrenal remnant tissue. A novel treatment modality for persistent Cushing's disease
ea0056p48
Risk estimator for autonomous cortisol secretion in adrenal incidentalomas. Retrospective study of 100 cases
ea0056p49
Is the adrenal vein sampling the gold standard diagnostic test for the subtyping of primary aldosteronism?
ea0056p50
A descriptive study of patients with adrenocortical carcinoma treated in hospital clinico san carlos (HCSC) over the last 20 years
ea0056p51
Bilateral adrenalectomy for occult ectopic Cushing's syndrome in two patients with catastrophic hypercortisolism
ea0056p52
In vitro effects of KCNJ5 mutations on cellular death mechanisms
ea0056p53
The role of DHEAS in the diagnosis of possible autonomous cortisol secretion by incidentally discovered adrenal adenomas
ea0056p54
Abnormal salivary cortisol result in patient with low probability of Cushing disease
ea0056p55
Improved salivary cortisol rhythm with dual-release hydrocortisone
ea0056p56
A case of adrenal Cushing's syndrome initially presenting with diabetic ketoacidosis
ea0056p57
The diagnostic accuracy of increased late night salivary cortisol for Cushing's Syndrome: a real-life prospective study
ea0056p58
Cardiovascular features of possible autonomous cortisol secretion in patients with adrenal incidentalomas
ea0056p59
Expert patients are better prepared to survive adrenal crisis than most - but still lack training in injection method
ea0056p60
Histopathological characteristics of lipid-poor adrenal adenomas
ea0056p61
Different biological and functional features in patients with Cushing's disease harboring micro- or macro-adenomas
ea0056p62
Salivary cortisol as a diagnostic tool for hypercortisolism in Cushing's syndrome and adrenal incidentaloma
ea0056p63
Bilateral macronodular adrenal hyperplasia with autonomous cortisol secretion
ea0056p64
A systematic survey of low S-cortisol levels at the department of clinical chemistry: indications for testing and frequency of undiagnosed adrenal insufficiency
ea0056p65
Evaluation of cardiometabolic profile of patients submitted to unilateral adrenalectomy
ea0056p66
Adrenal venous sampling in patients with ACTH-independent Cushing's syndrome
ea0056p67
Association of the BclI glucocorticoid receptor polymorphism with metabolic parameters in female patients with adrenal incidentalomas
ea0056p68
Adrenocortical carcinoma in the experience of one clinical center
ea0056p69
Adrenocortical carcinoma: retrospective analysis of a series of clinical cases
ea0056p70
Adrenal medulla
Imaging characteristics of pheochromocytomas
ea0056p71
Genetics in pheochromocytoma and paraganglioma: a case series
ea0056p72
Analysis of a pheochromocytoma case series over 12 years: a specialty hospital experience
ea0056p73
Laparoscopic surgery for pheochromocytoma: perioperative outcomes
ea0056p74
Malignant pheochromocytoma discovered upon consultation for painful erections
ea0056p75
Can patients with a large sporadic pheochromocytoma and very high norepinephrine secretion be normotensive? Yes, they can!
ea0056p76
Pheochromocytoma revelation modalities: about 23 cases
ea0056p77
When the large tumor is not the first intention for removal-concomitant discovery of left adrenal pheochromocytoma and a possible retroperitoneal plexiform neurofibroma in a case of familial neurofibromatosis type 1- case report
ea0056p78
Why is it important to screen secondary endocrine hypertension in resistant cases? Lessons from a patient with progressive renal failure
ea0056p79
Association of pheochromocytoma and neurofibrematosis type1: about 4 cases
ea0056p80
A retrospective audit on the peri-operative management of phaeochromocytomas: [ldquo]Phenoxybenzamine or Doxazosin[rdquo]?
ea0056p81
Calcium ' Vitamin D metabolism
25-OH vitamin D concentration and inflammation indicators in patients with non-functioning adrenal incidentalomas
ea0056p82
Cardiovascular Endocrinology and Lipid Metabolism
Arterial hypertension from the adrenal gland: Prognosis and predictive factors of recovery after chirurgical treatment
ea0056p83
Metabolic and hormonal profile in primary aldosteronism as compared with essential hypertension
ea0056p84
Aortic root dilatation in primary aldosteronism: is treatment effective in reducing aortic damage?
ea0056p85
Clinical case reports - Pituitary/Adrenal
Abstract unavailable
ea0056p86
Long-term follow-up of congenital adrenal hyperplasia due to 11[beta]-hydroxylase deficiency
ea0056p87
Rhabdomyolysis in a case with severe hypokalemia and Primary Hyperaldosteronism
ea0056p88
Pheochromocytoma in young patient-challenges in clinical practice
ea0056p89
Opioid-induced secondary adrenal insufficiency
ea0056p90
Intracerebral hemorrhage as a first sign of pheochromocytoma
ea0056p91
Severe pheochromocytoma crisis, Type B, resulting in Takotsubo-like cardiomyopathy and fulminant refractory cardiogenic shock, successfully treated with extracorporeal membrane oxygenation (ECMO) but with fatal neurological sequelae for the patient.
ea0056p92
Functionig adrenal incidentaloma false positive for 18F-FDG-PET/TAC
ea0056p93
Difficult Management of Autoimmune Polyglandular Syndrome Type 1
ea0056p94
Pitfalls in differential diagnosis of adrenal masses
ea0056p95
From gastric sleeve to diagnosis of a rare familial multiple endocrine neoplasia type 1
ea0056p96
Primary adrenal lymphoma in an HIV patient: a rare case of bilateral adrenal tumors
ea0056p97
High Adrenocorticotropic Hormone before and after bilateral adrenal surgery
ea0056p98
Addison's disease due to bilateral adrenal hemorrhage as the first presentation of diffuse large B-cell lymphoma
ea0056p99
17- [alpha] hydroxylase deficiency in an adult female patient with hypertention and hypokalemia
ea0056p100
Li-Fraumeni syndrome and adrenal tumours: case report
ea0056p101
Addison's disease due to bilateral adrenal hemorrhage as the firstpresentation of diffuse large B-cell lymphoma
ea0056p102
Paraganglioma of the prostate: a case report
ea0056p103
A new gene - TMEM127 - in familial pheochromocytoma/paraganglioma syndromes
ea0056p104
Bilateral adrenal mass revealing a pheochromocytoma and an adrenocortical adenoma in a young women: a case report
ea0056p105
Cushing's syndrome in a patient with systemic lupus erythematosus
ea0056p106
Clinical case reports - Thyroid/Others
Searching for the cause of high HCG in a man
ea0056p107
Syndrome carney-stratakis, new mutation report: SDH B: D138Y (c.412>T)
ea0056p108
Challenges in the diagnosis and treatment of GEP NEN: a case report
ea0056p109
Endocrine tumours and neoplasia
Ectopic adrenocorticotropic hormone syndrome: clinical features, diagnosis, treatment and long-term observation. Impact of bronchial carcinoid tumors
ea0056p110
Effect of 177 Lu-dotatate on severe, life-threatening, and refractory hypoglycemia associated with malignant insulinoma
ea0056p111
Morphological changes of the adrenal glands with hypertension with a crisis current
ea0056p112
Atypical manifestation of adrenocortical carcinoma - case series
ea0056p113
Are there any clinical predictor for malignancy in malignant pheochromocytoma?
ea0056p114
New cancer drug targets identified in adrenocortical carcinoma through gene expression profiling
ea0056p115
Outcome of adjuvant mitotane therapy in patients with adrenocortical carcinoma: the experience of San Luigi Gonzaga Hospital
ea0056p116
Adrenocortical carcinoma - characteristics and outcome of patients treated at Helsinki University Hospital during the last 15 years
ea0056p117
Comparative study between familial and sporadic pheochromocytoma
ea0056p118
Clinical features, management and outcomes of adrenocortical carcinoma: a case series analysis
ea0056p119
A case of multiple endocrine neoplasia type 1 (MEN1) with non-insulinoma pancreatogenous hypoglycemia syndrome (NIPHS) responding to medical treatment with diazoxide
ea0056p120
A case of benign insulinoma successfully treated with endoscopic ultrasound guided radiofrequency ablation
ea0056p121
Careful selection of patients with primary aldosteronism using combination of age, serum potassium and CT adrenal glands can avoid the need for adrenal venous sampling prior to adrenalectomy.
ea0056p122
Hormonal secretion prevalence in a series of subjects with adrenal tumors incidentally discovered in clinical practice
ea0056p123
Genetic background as a predictive factor of pheochromocytoma and paraganglioma presentation
ea0056p124
Heterogeneous genetic background of Hungarian patients with pheochromocytoma/paraganglioma requires gene panel testing
ea0056p125
Gastroenteropancreatic neuroendocrine tumors are predictive for a positive MEN1 germline mutation test: evidence from Hungarian MEN1 cohort
ea0056p126
Adrenocortical cancer - the effectiveness of mitotane therapy depending on the time of therapy and the therapeutic dose
ea0056p127
Ghrelin is overexpressed in adrenal cancers and stimulates proliferation and migration of ACC cell line.
ea0056p128
The effect of temozolomide on pancreatic neuroendocrine tumours and role of MGMT and MMR system in temozolomide resistance
ea0056p129
Treatment with (177Lu)-dotatate in patients with advanced metastatic somatostatin receptor-positive tumors
ea0056p130
Severe impairments in health-related quality of life in patients with small intestine neuroendocrine tumors
ea0056p131
Role of GLUT-2 expression and MGMT methylation for streptozotocin clinical response in adrenocortical carcinoma
ea0056p132
Presence and functional role of KiSS/KiSS-R system in pancreatic neuroendocrine tumors (panNETs) and its relationship with clinical features and tumor behavior
ea0056p133
Mesenchymal tissue markers as potential drug targets in adrenocortical tumours
ea0056p134
Multiple endocrine neoplasia type 1: a retrospective monocenter analysis of 73 cases
ea0056p135
Cell line derived from glioblastoma synthesizes steroid hormone. Effect of enzyme inhibitors
ea0056p136
Unraveling the incidence and clinical patterns of neuroendocrine neoplasms in Greece, through the experience of multipotent, specialized clinical centers.
ea0056p137
Evaluation of neurofibromatosis type 1 and gastroenteropancreatic neuroendocrine tumors.
ea0056p138
Prevalence of undiagnosed Medullary Thyroid Carcinoma and Phaeochromocytoma in MEN2A syndrome revealed by cascade screening
ea0056p139
Achievement of therapeutic mitotane concentrations in management of advanced adrenocortical cancer: a single centre experience in 47 patients
ea0056p140
Patients with metastatic bone disease and neuroendocrine neoplasms: the experience of a multi-center study
ea0056p141
Clinical features of 'dedifferentiation' in advanced pancreatic neuroendocrine neoplasms: the experience of two centers of excellence
ea0056p142
Clinical features of a gastric neuroendocrine neoplasms type 1 series
ea0056p143
Female Reproduction
Female fertility in congenital adrenal hyperplasia
ea0056p144
Neuroendocrinology
Non-functional duodenal neuroendocrine carcinoma- a rare cause of diabetes mellitus
ea0056p145
Preliminary study of POU1F1 (Pit1) gene expression in lactotroph and thyrotroph neuroendocrine tumours
ea0056p146
Ectopic cushing's syndrome: Six cases description
ea0056p147
Metastatic meduller thyroid cancer patient with MEN 2B who developed acute leukemia
ea0056p148
Diagnostic difficulties, management and treatment in neuroendocrine tumors
ea0056p149
Through five hospitals and 800 km, a long way from emergency department to insulinoma operation
ea0056p150
A rare association of neuroendocrine tumors
ea0056p151
Head and neck paragangliomas: genetic mutation and location of the tumors
ea0056p152
Bilateral neck paragangliomas in a patient with a family history and chronic hypoxemia
ea0056p153
The first experience of using of ultrasound with multimodal imaging technology for the diagnosis of pancreatic insulinoma
ea0056p154
Obesity
Body composition and concentration of 25-OH vitamin D as metabolic syndrome indicators in patients with non-functioning adrenal incidentalomas
ea0056p155
Paediatric endocrinology
Pediatric adrenal insufficiency: experience from a Tertiary Hospital Center
ea0056p156
Pituitary - Basic
MicroRNA profile after octreotide treatment in neuroendocrine tumor cell line
ea0056p157
Gender differences in delays to diagnosis of acromegaly: data from the Swedish National Patient Register
ea0056p158
Direct costs after diagnosis of acromegaly: Data from Swedish nationwide registries
ea0056p159
Steroid metabolism + action
Urinary steroid profile in patients with primary adrenal insufficiency under conventional glucocorticoid replacement: a case control study
ea0056p160
Steroid profile using gas chromatography tandem mass spectrometry (GC-MS/MS) in search for a steroid which correlates most with subclinical hypercortisolism
ea0056p161
Thyroid (non cancer)
Clinical aspects of the schmidt's syndrome: a 14 years retrospective monocentric study
ea0056p162
Thyroid cancer
Abstract unavailable
ea0056p163
Poster Presentations: Calcium and Bone
Bone ' Osteoporosis
Influence of the levels of vitamin D on T-score in HIP measured by DXA of colombian postmenopausal women
ea0056p164
Potential extension of frax algoritm and probability of bonefracture
ea0056p165
A case report: FGF23-related tumor-induced osteomalacia in a patient with pulmonary adenocarcinoma
ea0056p166
Abstract unavailable
ea0056p167
Features of distal forearm fracture in persons 50 years old and older
ea0056p168
Effect of surgery vs observation: 6-Year skeletal outcomes in primary hyperparathyroidism
ea0056p169
Association between Serum FGF21 levels and bone mineral density in healthy postmenopausal Korean women
ea0056p170
Bone geometry is correlated with arterial stiffness in overweight older adults with vitamin D insufficiency
ea0056p171
Effects of acromegaly on plasma microRNA levels relevant to bone metabolism.
ea0056p172
Is FGF23 a key factor in primary hyperparathyroidism?
ea0056p173
Long-term monitoring of echinococcal cyst as a cause of increased lumbar bone mineral density
ea0056p174
Acromegaly patients with vertebral fractures, have lower trabecular bone score despite no difference in bone mineral density, than non-fractured patients and healthy controls
ea0056p175
Atypical femoral fracture-a possible complication in long term use of bisphosphonates (case report)
ea0056p176
Malignant hypercalcemia induced by denosumab discontinuation in a patient with primary hyperparathyroidism
ea0056p177
An extremely high risk of recurrent fractures in an elderly patient, identified with the implementation of Fracture Liaison Service (FLS) in a trauma hospital.
ea0056p178
The comparison of parathyroid neoplasms mappings evaluated by using gray scale ultrasound images and histopathological whole slide images
ea0056p179
Evaluation of bone mineral density and vertebral fracture incidence in a group of kidney transplant recipients
ea0056p180
PTH correlates with bone turnover serum markers in patients with end stage renal disease
ea0056p181
Rapid washout in primary, secondary, and tertiary hyperparathyroidism and utility of dual radiopharmaceutical acquisition with 99 Tc-sestamibi-123I for localization of parathyroid adenomas
ea0056p182
Trabecular bone score in patients with active acromegaly
ea0056p183
Gut and bone connection: celiac disease presented as hypertrophic osteoarthropathy
ea0056p184
The main bone mass predictors in healthy young and middle-aged men: lean mass and estradiol
ea0056p185
Teriparatide treatment in a patient with atypical femoral fractures associated with long-term bisphosphonate therapy
ea0056p186
Detection of pulmonary metastases with 18F-Fluorocholine PET/CT and treatment of refractory hypercalcemia with denosumab in a patient with long term parathyroid carcinoma
ea0056p187
Bone mineral density decline following denosumab discontinuation might not be attenuated with previous bisphosphonate therapy
ea0056p188
Novel heterozygous mutation of tissue-non-specific alkaline phosphatase (TNSALP) gene causing late-onset hypophosphatasia
ea0056p189
Orthopedic patient with hearing impairment and dizziness due to the undiagnosed Paget's disease of bone
ea0056p190
Tumor-induced osteomalacia associated with mesenchymal tumor: a challenging case report
ea0056p191
Osteoprotegerin and bone metabolism markers in postmenopausal women with primary hyperparathyroidism
ea0056p192
Endocrine osteoporosis characteristics (about 177 cases)
ea0056p193
Osteoprotegerin and distal radius bone mineral density in postmenopausal women with primary hyperparathyroidism
ea0056p194
Cystic fibrosis-related bone disease in young adults affected with cystic fibrosis awaiting lung transplantation for end-stage respiratory failure
ea0056p195
Recurrent vertebral fracture after denosumab discontinuation in a male patient with severe osteoporosis
ea0056p196
Microindentation in the study of bone properties for type 1 diabetes mellitus patients
ea0056p197
Relationships between hormonal parameters, body fat distribution and bone mineral density in women with menstrual disorders
ea0056p198
Long term follow up of patients with hypophosphatemic rickets in a Public Institution in Brazil
ea0056p199
Genetic polymorphisms may modulate bone and energy metabolism of mountain cycling ultramarathon athlete's
ea0056p200
May polymorphisms of DHFR, CBS and MTHFR genes modulate metabolic and bone remodeling parameters associated with reduced bone mineral density?
ea0056p201
Calcium & Vitamin D metabolism
Vitamin D levels in two ethnic groups of patients with diabetes
ea0056p202
Effects of steroid hormone on Calbindin-D9k expression in rat cerebellum
ea0056p203
Effects of glucocorticoid on mucin secretion by calcium-related proteins in mouse lung
ea0056p204
Effect of endocrine disrupting chemicals on the calcium channel and implantation during implantation period
ea0056p205
Clinical, paraclinical, etiological and therapeutic particularities of severe hypercalcemia: A comparative study
ea0056p206
Genetic characteristics of sensitivity of vitamin D and prevalence of vitamin deficiency among patients of polyclinics
ea0056p207
A Curious phenomenon of Post radioiodine therapy induced hypocalcemia in Graves' disease: Case series
ea0056p208
Primary hyperparathyroidism in the elderly
ea0056p209
Edentulous jaw and Primary HyperParathyroidism
ea0056p210
Coeliac Disease complicating Autoimmune Hypoparathyroidism with Recalcitrant Hypocalcaemia
ea0056p211
The prevalence of Vitamin D deficiency in a Greek and a Cypriot population sample
ea0056p212
Epidemiology of primary hyperparathyroidism in Santander, Spain
ea0056p213
Human Chorionic Gonadotrophin (hCG) as a diagnostic test to differentiate between Parathyroid Carcinoma, Primary Benign Hyperparathyroidism and Secondary Hyperparathyroidism.
ea0056p214
Reliabilty of serum Calcium to Phosphorus (Ca/P) ratio as an accurate and inexpensive toolto define disorders of Ca-P metabolism: preliminary data
ea0056p215
Secondary hyperparathyroidism after obesity surgery is associated with serum levels of 25-hydroxyvitamin D and ionized calcium
ea0056p216
The frequencies of persistent hyperparathyroidism and hypercalcemia after kidney transplantation: a single-center experience
ea0056p217
Prevalence and clinico-epidemiology of vitamin D deficiency in patients with type 2 diabetes mellitus and hypertension - a Pan-India study
ea0056p218
PTH threshold for hyperparathyroidism diagnosis in vitamin D deficiency
ea0056p219
Vitamin D status in hospitalized chronic ill patients
ea0056p220
Role of 4D-TC in Primary Hyperparathyroidism Diagnosis- case report
ea0056p221
Severe hypomagnesaemia and hypocalcaemia: an uncommon but serious complication with proton pump inhibitor therapy
ea0056p222
Hip fractures and vitamin D deficiency
ea0056p223
Clinical manifestation of Hypoparathyroidism in a monocentric cohort: our experience
ea0056p224
Primary hyperparathyroidism due to a parathyroid adenoma with cystic degeneration presenting as recurrent acute pancreatitis
ea0056p225
Glucose metabolism in primary hyperparathyroidism: The role of parathyroidectomy
ea0056p226
Acquired Fanconi syndrome and hypophosphatemic osteomalacia in two patients treated with adefovir and tenofovir
ea0056p227
The coexistence of primary hyperparathyroidism with different auto-antibodies and autoimmune diseases
ea0056p228
Timely and dose assessment of serum parathormone and calcium levels by cinacalcet in patients with primary hyperparathyroidism: an individualized approach
ea0056p229
Coexistence of a large functioning parathyroid cyst with papillary thyroid carcinoma: a case report
ea0056p230
Assessment of calcium and vitamin D medications adherence in patients with hypoparathyroidism after thyroidectomy
ea0056p231
Preoperative serumvitamin D levels in patients with breast cancer: association with histological characteristics
ea0056p232
Association of vitamin D status with pulmonary function: potential mediation by physical function and inflammation
ea0056p233
Quantification of serum 25-hydroxyvitamin D: a comparison between competitive chemiluminescence immunoassay and mass spectrometry coupled to high performances liquid chromatography
ea0056p234
Maximal foot force and plantar pressure distribution assessed by Footscan is not affected in asymptomatic primary hyperparathyroidism patients
ea0056p235
Primary hyperparathyroidism in Russian Federation: epidemiology according to the online register
ea0056p236
Intrathyroidal parathyroid carcinoma in a chronic hemodialysis patient: a case report
ea0056p237
Raloxifene has no efficacy in reducing the risk of spontaneous vertebral fractures after denosumab discontinuation
ea0056p238
Prevalence of basal ganglia calcification in patients with pseudohypoparathyroidism
ea0056p239
Thyroid oncocytes may complicate 18F-fluorocholine PET-CT localization of parathyroid adenomas in primary hyperparathyroidism
ea0056p240
Burden of illness among patients with chronic hypoparathyroidism not adequately controlled with standard therapy by self-perception
ea0056p241
Abstract unavailable
ea0056p242
PTH secretion dynamics in patients with chronic kidney disease stage 3 and stage 4 during 1 year of observation
ea0056p243
Biological and endocrine features of Infra Clinical Hypoparathyroidism in Major Beta Thalassemia at adulthood in Algeria, screening and therapeutic management
ea0056p244
Impact of vitamin D status in clinical, biochemical, radiological and pathological parameters in primary hyperparathyroidism
ea0056p245
Milk alkali syndrome & soft tissue calcification in a patient with a history of cancer
ea0056p246
Management of parathyroid adenomas
ea0056p247
Recurrent hyperparathyroidism: parathyroid carcinoma or parathyromatosis?
ea0056p248
Prenatal hypophosphatasia with severe skull bone deficits report of a case
ea0056p249
Clinical outcome in primary hyperparathyroidism: A 10-year tertiary care centre experience in Pakistan
ea0056p250
Primary hyperparathyroidism-localisation studies' sensitivity
ea0056p251
Characterization of the parathyroid hormone requests and hyperparathyroidism etiologies in a tertiary hospital
ea0056p252
Tertiary hyperparathyroidism associated with prolactinoma - case report
ea0056p253
Effect of bariatric surgery on free vitamin D3 levels
ea0056p254
Utility of contrast-enhanced ultrasound in preoperative evaluation of primary hyperparathyroidism
ea0056p255
Abstract unavailable
ea0056p256
Primary hyperparathyroidism after thyroid surgery and autotransplantion of parathyroid gland
ea0056p257
Metabolic encephalopathy following intravenous zolendronate for hypercalcaemia of malignancy: a perfect storm
ea0056p258
Primary hyperparathyroidism: a rare cause of hypertension?
ea0056p259
Atypical Parathyroid adenoma in a young individual, presented with nephrocalcinosis
ea0056p260
Cardiovascular Endocrinology and Lipid Metabolism
Is there a relationship between mean platelet volume as a cardiac marker and serum calcium levels in patients with parathyroid disease
ea0056p261
Clinical case reports - Pituitary/ Adrenal
Hypercalcemia, hypercortisolism and multiple vertebral fractures in a 49-year-old man
ea0056p262
Clinical case reports - Thyroid/Others
Severe hypercalcemia due to atypical parathyroid adenoma
ea0056p263
Functional hypoparathyroidism secondary to magnesium deficiency in long-term users of proton pump inhibitor: case report
ea0056p264
Utility of 11C-methionine PET/CT in preoperative localization of a parathyroid adenoma in a patient with primary hyperparathyroidism: a case report
ea0056p265
Ulnar osteoclastoma as first manifestation in primary hyperparathyroidism: case report
ea0056p266
Lithium-associated Hyperparathyroidism in a Filipino woman presenting as recurrent ischemic stroke: a case report
ea0056p267
Looked like a goiter, proved to be a giant parathyroid adenoma
ea0056p268
Concomitant primary hyperparathyroidism with papillary thyroid carcinoma: The role of dual-phase 99mTc-MIBI parathyroid imaging: case report
ea0056p269
Multiple brown tumors inprimary hyperparathyroidismcaused by an adenoma mimicking metastatic bone disease with false positive results on computed tomography
ea0056p270
Regression of multipl brown tumors after surgical removal of mediastinal ectopic parathyroid adenoma
ea0056p271
Multiple hormone resistance in a patient with follicular thyroid carcinoma and papillary microcarcinoma
ea0056p272
Hypercalcemia not mediated by PTH: a case report
ea0056p273
Papillary thyroid cancer and primary hyperparathyroidism - a rare coincidence: case report
ea0056p274
Endocrine Disruptors
Role of Pro-inflammatory cytokines in Primary Hyperparathyroidism: A Prospective Study
ea0056p275
Endocrine Nursing
Prevalence of kidney stones and osteoporosis in patients with primary hyperparathyroidism
ea0056p276
Endocrine tumours and neoplasia
Somatostatin receptors 1 and 5 are novel markers of parathyroid tumor aggressiveness
ea0056p277
Vitamin D and cancer of the prostate
ea0056p278
Feasibility and efficacy in ultrasound guided percutaneous microwave ablation of primary hyperparathyrodism with parathyroid nodules
ea0056p279
Female Reproduction
Association between age at onset of menopause and fracture risk: a systematic review and meta-analysis
ea0056p280
Poster Presentations: Diabetes, Obesity and Metabolism
Adrenal cortex (to include Cushing's)
Hypoglycemia in non-diabetic patients: clinical features and causes
ea0056p281
Bone & Osteoporosis
First report of Gaucher disease in Montenegro: Genotype/phenotype correlations
ea0056p282
Hip axis length in women with type 1 diabetes mellitus
ea0056p283
Vertebral fractures in patients with type 2 diabetes mellitus
ea0056p284
Vertebral fractures in women with type 1 diabetes mellitus
ea0056p285
Proximal femur structural geometry changes in women with type 2 diabetes mellitus
ea0056p286
Case report: male adult with autosomal-dominant osteopetrosis
ea0056p287
Fragility index in type 2 diabetes for identification of patients with risk of osteoporotic fracture or prevalent fracture
ea0056p288
Calcium & Vitamin D metabolism
Relationships between vitamins and lipids in the elderly
ea0056p289
Vitamin D and obesity
ea0056p290
Vitamin D deficiency and risk of metabolic syndrome
ea0056p291
Cardiovascular Endocrinology and Lipid Metabolism
Effects of atorvastatin and ezetimibe therapy on LDL Cholesterol. A systematic review and meta-analysis of randomized controlled trial
ea0056p292
Your patients say they do not tolerate statins? You can still lower their cardiovascular risk with red yeast rice supplementation
ea0056p293
Lobeglitazone, a novel thiazolidinedione, improves hepatic steatosis in diet-induced obese mice
ea0056p294
B-type natriuretic peptide: a biomarker of cardiovascular risk in type 2 diabetes.
ea0056p295
Relationship between the triglyceride glucose index and the presence and fibrosis of nonalcoholic fatty liver disease in Korean adults
ea0056p296
Adropin concentration correlates with selected anthropometric and biochemical parameters - preliminary report
ea0056p297
Silent myocardial ischemia in type 2 diabetes patients with ischemic heart disease
ea0056p298
PCSK9 inhibitors as an add on for the treatment of dislipemia in real clinical practice
ea0056p299
Treatment adherence through an Integral Care Program for patients with Metabolic Syndrome in Central Mexico
ea0056p300
Searching the best feeding habits to improve atherogenic dyslipidemia and inflammatory activity in patients with psoriatic arthritis
ea0056p301
Worse MELD score is linked to a higher rate of metabolic syndrome in HIV/HCV co-infected patients on highly active antiretroviral therapy
ea0056p302
Improved lipid profile and cardiovascular risk factors after bariatric surgery
ea0056p303
Efficacy and safety of proprotein convertase subtilisin/kexintype nine inhibitors in real life experience
ea0056p304
Plasma insulin levels in patients with the different severity of atherosclerotic lesions of coronary arteries
ea0056p305
A multi-disciplinary approach to the management of NAFLD improves both liver and metabolic health and is cost effective
ea0056p306
A case of combined dyslipidemia with two different defined genetic alterations
ea0056p307
Soluble ST2, a promising cardiovascular biomarker, is associated with parameters of glucose and bone metabolism in subjects at cardiovascular risk
ea0056p308
Comparison of inflamatory parameters, lipid profile and clinical values in patients with clinical and subclinical hypothyroidism
ea0056p309
High levels of sclerostin are related to cardiovascular mortality
ea0056p310
Lipid profile after pregnancy in women with gestational diabetes mellitus
ea0056p311
Secondary diabetes associated with principal endocrinopathies (about 161 cases)
ea0056p312
Metabolic syndrome and triglyceride-rich lipoproteins
ea0056p313
Specificity of mathematical indexes versus histopathological findings in the diagnosis of nonalcoholic fatty liver disease in mexican population
ea0056p314
What changes does pregnancy bring to the lipid parameters of diabetic patients?
ea0056p315
Identifying metabolic unhealthy obesity using the product of triglycerides and glucose
ea0056p316
Clinical case reports - Thyroid/Others
Diabetic ketoacidosis occurring in the patient whom newly started insulin glargine U300: a case report
ea0056p317
A female patient with diabetic ketoacidosis who had hyperthyroidism and acute appendicitis
ea0056p318
Factitious hypoglycemia; Case report
ea0056p319
Development of fatal lactic acidosis after inadvertent use of metformin in a non-diabetic hemodialysis patient
ea0056p320
Effect of hemoglobin J variant on HbA1c values as measured by HPLC (high-perfomance liquid chromatography)
ea0056p321
Performance-enhancing drugs and adverse endocrine effects
ea0056p322
Maturity - onset diabetes in the young and non-alcoholic fatty liver disease: a case report
ea0056p323
Dapagliflozin and Atkins Diet in a patient with type 2 Diabetes Mellitus: A combination that should be avoided
ea0056p324
A rare cause of hypoglycemia: insulin autoimmune syndrome in a Turkish patient taking Alpha lipoic acid
ea0056p325
Post bariatric surgery malabsorption and vitamin D deficiency
ea0056p326
Diabetes and bulimia - a dangerous combination
ea0056p327
Prolonged hyperglycemia in a type 1 diabetic futsal player after a single betamethasone injection for pain in the groin area
ea0056p328
Developmental endocrinology
Glucose, lipids, and insulin in cord blood of neonates and their association with birth weight
ea0056p329
Association of RS1170806 polymorphism in ADCY5 and RS7754840 polymorphism in CDKAL1 with birth weight, neonatal glucose, insulin and insulin resistance.
ea0056p330
Diabetes (to include epidemiology, pathophysiology)
Evaluation of community pharmacy-based services for type-2 diabetes in an Albanian setting: pharmacist survey
ea0056p331
Estimation of HbA1c in hospitalized patients with bronchial asthma
ea0056p332
Inpatient diabetes management service, 30-day readmissions and length of stayof patients with diabetes
ea0056p333
Evolution of the degree of glycemic control in a cohort of patients with type 2 diabetes mellitus. study to 26 weeks
ea0056p334
Study of the association of transcription factor 7 like 2 gene polymorphism with type 2 diabetes mellitus and diabetic nephropathy in the Egyptian population
ea0056p335
Relationship between serum zinc, glycemic status and HOMA2 parameters in a regional Australian hospital population
ea0056p336
The role of polysomnography for detection of OSA in patients with type 2 diabetes in the Uzbek population
ea0056p337
Transcription Factor 7 Like2 Gene Polymorphisms and Susceptibility to Type 2 Diabetes Mellitus in a cohort of Egyptian diabetic patients, a pilot study
ea0056p338
Undiagnosed diabetes and related risk factors in postmenopausal women: the 2011-2012 Korean National Health and Nutrition Examination Survey
ea0056p339
Comparison of quality of life and symptoms of depression in diabetes combined with gastroparesis and without it
ea0056p340
Predictors of anxiety development at diabetes mellitus type 1
ea0056p341
Comparative analysis of the prevalence of type 2 diabetes according to the screening and register data in Uzbekistan
ea0056p342
Nutrition of non-fasting patients with diabetes during the month of Ramadan
ea0056p343
Evaluation of procalcitonin levels in diabetic and diabetic nephropathic patients
ea0056p344
Telmisartan increases gluconeogenesis by inducing PKCζ-Thr410 phosphorylation in hyperglycemia-treated HepG2 cells and high-fat diet-fed mouse liver
ea0056p345
Diabetes complications and comorbidities in patients newly diagnosed with diabetes in newfoundland and labrador (NL): gender differences
ea0056p346
Visfatin concentration and anthropometric/biochemical parameters in healthy individuals-preliminary study
ea0056p347
Serum soluble vascular adhesion molecules and highly sensitive C: reactive protein in elderly type 2 diabetic patients with mild cognitive impairment
ea0056p348
Evaluating quality of diabetic care in patients with severe mental illness (SMI) in an academic primary care clinic
ea0056p349
Prorenin and secreted frizzled-related protein-4 levels in women with gestational diabetes mellitus
ea0056p350
Novel inflammatory pathways in monocytes of type 2 diabetes patients are modulated by vitamin D
ea0056p351
Serum adiponectin in male type 2 diabetic patients exposed to ionizing radiation in early years
ea0056p352
Decreased spexin levels in patients with type 1 diabetes
ea0056p353
Increase in C-peptide levels after short term glycemic control in patients with type 2 diabetes mellitus: myths or facts?
ea0056p354
Incidence of glucocorticoid-induced hyperglycemia among hospitalized nondiabetic patients
ea0056p355
Diabetes after liver transplantation
ea0056p356